Esomeprazole and omeprazole may boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) leading to greater adverse effects including drowsiness, Even though the clinical relevance is low for most individuals – observe the affected person for adverse effects (e.If affected person cannot resume their standard oral medication